Kristel M. L. Crommentuyn

Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs

Maarten T. Huisman, Johan W. Smit, Kristel M. L. Crommentuyn et al. · AIDS · 2002 · 223 citations

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV‐1‐infected patients

Kristel M. L. Crommentuyn, Bregt S Kappelhoff, Jan W. Mulder et al. · British Journal of Clinical Pharmacology · 2005 · 71 citations · Full text

Ritonavir Plasma Concentrations, Pharmacotherapy, Population Pharmacokinetics +23

Indinavir/ritonavir‐based therapy in HIV‐1‐infected antiretroviral therapy‐naive patients: comparison of 800/100 mg and 400/100 mg twice daily

Déborah Konopnicki, Bénédicte Poll, Kristel M. L. Crommentuyn et al. · HIV Medicine · 2005 · 69 citations · Full text

The Plasma and Intracellular Steady-State Pharmacokinetics of Lopinavir/Ritonavir in HIV-1-Infected Patients

Kristel M. L. Crommentuyn, Jan W. Mulder, Albert T.A. Mairuhu et al. · Antiviral Therapy · 2004 · 63 citations · Full text

A Pharmacokinetic and Pharmacogenetic Study of Efavirenz in Children: Dosing Guidelines can Result in Subtherapeutic Concentrations

Robter Heine, Henriëtte J. Scherpbier, Kristel M. L. Crommentuyn et al. · Antiviral Therapy · 2008 · 62 citations